Skip to content
OpenCapital
Get started

Benitec Biopharma Inc. BNTC Q4 2024 earnings

Reported February 14, 2025 · Before market open

EPS-$0.36Beat by $0.64
EPS estimate-$1.00

Next report

Sep 28, 2026 (in 2 months)
EPS estimate-$0.25

Versus estimates

Revenue

Q2 2025$556.0K

Diluted EPS

Q1 2026-$0.24Beat by $0.03Q4 2025-$0.26Miss by $0.03Q3 2025-$0.22Beat by $0.13Q2 2025-$0.42Miss by $0.14Q1 2025-$0.24Beat by $0.12
Q4 2024-$0.36Beat by $0.64

Ask the moment Benitec Biopharma Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Benitec Biopharma Inc. report Q4 2024 earnings?
Benitec Biopharma Inc. (BNTC) reported Q4 2024 earnings on February 14, 2025 before market open.
What were Benitec Biopharma Inc.'s Q4 2024 revenue and EPS?
Benitec Biopharma Inc. reported eps of $-0.36 for Q4 2024.
Did Benitec Biopharma Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-1.00 by $0.64.
Where can I find Benitec Biopharma Inc.'s Q4 2024 SEC filings?
You can read the 10-Q periodic report (0001193125-25-026631) directly on SEC EDGAR. The filing index links above go to sec.gov.